The Business Journals

ArQule spins out Boston Biomedical with $5M research deal

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Woburn-based biotechnology firm ArQule Inc.'s former chief ...
Business Insider

Boston Biomedical Announces First Patient Dosed with Investigational Toll-like Receptor (TLR) 7 Agonist DSP-0509 in Phase 1 Trial of Patients with Advanced Solid Tumors ...

CAMBRIDGE, Mass., Sept. 13, 2018 /PRNewswire/ -- Boston Biomedical, Inc., a leading developer of novel cancer therapeutics with the goal of significantly improving patient outcomes, today announced ...
Business Insider

Boston Biomedical, Inc. Announces Investment by its Parent Company in MPM Oncology Innovations Fund

CAMBRIDGE, Mass., March 2, 2020 /PRNewswire/ -- Boston Biomedical, Inc. announced today that its parent company, Sumitomo Dainippon Pharma Co., Ltd. (Osaka, Japan) has invested in the MPM Oncology ...
BioWorld

Boston Biomedical Morphs Deal Into $2.6B Dainippon Buyout

Less than a year after picking up several regional options to Boston Biomedical Inc.'s lead cancer stem cell drug BBI608, Dainippon Sumitomo Pharma Co. Ltd. skipped exercising those options in favor ...
Business Wire

Boston Biomedical Associates Broadens its Portfolio with a Focus on Strategic Technology Development as Stefan Schreck, PhD Joins the Senior Management Team

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Boston Biomedical Associates (BBA) is proud to announce that Dr. Stefan Schreck has joined the management team as Executive Director, Science and Technology where ...